Clinical Trials

22 enrolled

Lymphoma, Neoplasms, Recurrence

NCT07337785 2026-01-22

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

36 enrolled

Multiple Sclerosis, Myasthenia Gravis, Recurrence, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT07330895 2026-01-09

Clinical Study of LV009 Injection in the Treatment of Recurrent/Refractory CD19 Positive Blood Tumors

Phase EARLY_PHASE1 Active not recruiting

19 enrolled

Recurrence

NCT04656535 2026-01-07

AB154 Combined With AB122 for Recurrent Glioblastoma

46 enrolled

Glioblastoma, Recurrence

NCT07240974 2025-11-21

Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell Malignancies

Phase EARLY_PHASE1 Active not recruiting

6 enrolled

Recurrence

NCT05634707 2025-09-22

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

Brain Neoplasms, Glioma, Recurrence

NCT06986434 2025-09-03

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms

Recurrence, Neoplasms, Plasma Cell

NCT05779930 2025-08-15

Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

LymphoidOther hematologic neoplasm

12 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01748149 2025-08-03

Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas

40 enrolled

Recurrence

NCT07077330 2025-07-22

CAR19BCMA

Phase EARLY_PHASE1 Terminated

Recurrence, Neoplasms, Plasma Cell

NCT04034446 2025-06-03

CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)

2 enrolled

Burkitt Lymphoma, Recurrence

NCT06972602 2025-05-15

High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed

Other solid neoplasm

Recurrence, Retinoblastoma

NCT01184885 2025-05-04

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

LymphoidOther hematologic neoplasm

7 enrolled 8 charts

Burkitt Lymphoma, Recurrence, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05432518 2025-04-25

Pilot Trial for Treatment of Recurrent Glioblastoma

Glioblastoma, Recurrence

NCT06837389 2025-02-20

Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors

Other hematologic neoplasm

18 enrolled

Recurrence, Hematologic Neoplasms

NCT05651178 2025-01-07

Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients

Lymphoma, Recurrence

NCT06684639 2024-12-20

A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma

30 enrolled

Neuroblastoma, Recurrence

NCT06732232 2024-12-13

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma

12 enrolled

Multiple Myeloma, Recurrence

NCT06718270 2024-12-12

a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia

Other hematologic neoplasmPlasma cell

24 enrolled

Leukemia, Plasma Cell, Multiple Myeloma, Recurrence

NCT06298266 2024-03-07

To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma

15 enrolled

Multiple Myeloma, Recurrence

NCT06104215 2023-10-27

BGT007H Cells for the Treatment of Refractory Digestive System Tumors

14 enrolled

Recurrence

NCT06104241 2023-10-27

BGT007 Cells for the Treatment of Refractory Digestive System Tumors

14 enrolled

Gastrointestinal

Gastrointestinal Neoplasms, Recurrence

NCT05105867 2023-05-10

CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies

15 enrolled

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT05559177 2022-09-29

An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer

9 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT04626752 2020-11-13

CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma

50 enrolled

Multiple Myeloma, Recurrence

NCT04603872 2020-10-28

CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

LymphoidOther hematologic neoplasmPlasma cell

120 enrolled

Lymphoma, Non-Hodgkin, Multiple Myeloma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04283006 2020-08-21

A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies

100 enrolled

Recurrence

NCT04315584 2020-03-24

FDG and FDOPA PET Demonstration of Functional Brain Abnormalities

5 enrolled

Glioblastoma, Recurrence

NCT04169932 2019-11-20

The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, B-Cell

NCT04028440 2019-09-26

γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

LymphoidOther hematologic neoplasm

6 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, T-Cell, Peripheral

NCT04011293 2019-07-08

A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies

Other hematologic neoplasm

Neoplasms, Recurrence, Hematologic Neoplasms

NCT02646319 2019-06-06

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations